Total Payments
$946.65
2024 Payments
$477.34
Companies
13
Transactions
44
Medicare Patients
1,187
Medicare Billing
$112,019
Payment Breakdown by Category
Food & Beverage$946.65 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $946.65 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $286.64 | 13 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $125.65 | 5 | $0 (2023) |
| Lilly USA, LLC | $112.74 | 5 | $0 (2024) |
| AbbVie Inc. | $69.72 | 4 | $0 (2023) |
| Amgen Inc. | $65.13 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.37 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $46.29 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $41.42 | 2 | $0 (2024) |
| Novo Nordisk Inc | $37.12 | 2 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $36.89 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $477.34 | 21 | AstraZeneca Pharmaceuticals LP ($203.86) |
| 2023 | $248.14 | 11 | NESTLE HEALTHCARE NUTRITION INC. ($100.85) |
| 2022 | $69.26 | 3 | Nestle HealthCare Nutrition Inc. ($24.80) |
| 2021 | $45.75 | 2 | Novo Nordisk Inc ($22.92) |
| 2018 | $15.88 | 1 | Merck Sharp & Dohme Corporation ($15.88) |
| 2017 | $90.28 | 6 | AstraZeneca Pharmaceuticals LP ($47.96) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Oncology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiology | ||||||
| 05/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: DIABETES | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $52.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: VACCINES | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: VACCINES | ||||||
| 12/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: DIABETES | ||||||
| 10/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 08/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 266 | 592 | $45,776 | $28,447 |
| 2022 | 5 | 281 | 649 | $52,787 | $31,654 |
| 2021 | 5 | 281 | 596 | $49,937 | $28,843 |
| 2020 | 8 | 359 | 774 | $44,555 | $23,075 |
Total Patients
1,187
Total Services
2,611
Medicare Billing
$112,019
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 338 | $39,593 | $24,300 | 61.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 155 | $1,550 | $1,302 | 84.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,735 | $1,065 | 61.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $960.00 | $802.08 | 83.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 24 | 24 | $1,200 | $491.04 | 40.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 39 | $738.20 | $486.33 | 65.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 396 | $48,197 | $29,530 | 61.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $920.00 | $761.07 | 82.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 100 | 177 | $1,770 | $524.82 | 29.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 23 | 23 | $1,150 | $461.61 | 40.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 30 | $750.00 | $377.05 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 359 | $43,587 | $25,855 | 59.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $2,850 | $1,592 | 55.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 99 | 174 | $1,740 | $522.00 | 30.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 22 | 22 | $880.00 | $451.66 | 51.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $880.00 | $422.18 | 48.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 366 | $34,770 | $19,467 | 56.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,100 | $957.06 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 39 | 39 | $1,560 | $739.44 | 47.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 31 | 51 | $2,295 | $547.08 | 23.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 25 | 25 | $1,000 | $489.50 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 96 | 161 | $1,610 | $479.94 | 29.8% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 14 | 14 | $700.00 | $387.80 | 55.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 22 | 104 | $520.00 | $7.68 | 1.5% |
About Dr. Sangjun Byeon, MD
Dr. Sangjun Byeon, MD is a Family Medicine healthcare provider based in Rowland Heights, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659574945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sangjun Byeon, MD has received a total of $946.65 in payments from pharmaceutical and medical device companies, with $477.34 received in 2024. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($946.65).
As a Medicare-enrolled provider, Byeon has provided services to 1,187 Medicare beneficiaries, totaling 2,611 services with total Medicare billing of $112,019. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rowland Heights, CA
- Active Since 06/06/2007
- Last Updated 07/18/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659574945
Products in Payments
- FARXIGA (Drug) $222.16
- ZENPEP (Drug) $152.66
- JARDIANCE (Drug) $120.92
- Repatha (Biological) $65.13
- AIRSUPRA (Drug) $64.48
- Vascepa (Drug) $46.29
- AMYVID (Drug) $44.19
- Ozempic (Drug) $37.12
- JANUVIA (Drug) $36.89
- Cologuard Collection Kit (Device) $27.34
- CREON (Drug) $26.46
- LINZESS (Drug) $21.95
- SHINGRIX (Biological) $21.52
- Creon (Drug) $21.31
- TRELEGY ELLIPTA (Drug) $19.90
- PREVNAR 20 (Biological) $18.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rowland Heights
Dr. Angela Cherlin, M.d, M.D
Family Medicine — Payments: $7,268
Family Medicine $7,268
Dr. Tin Yung, M.d, M.D
Family Medicine — Payments: $2,986
Family Medicine $2,986
Chris Lee, M.d, M.D
Family Medicine — Payments: $2,712
Family Medicine $2,712
Adam Hy, D.o, D.O
Family Medicine — Payments: $2,653
Family Medicine $2,653
Dr. Gene Tu, Md, MD
Family Medicine — Payments: $2,297
Family Medicine $2,297
Dr. Marc Ma, M.d, M.D
Family Medicine — Payments: $767.39
Family Medicine $767.39